Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD

S. Everaerts (LEUVEN, Belgium)

Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Session: Towards personalised medicine in COPD: biological and clinical phenotypes
Session type: Oral Presentation
Number: 509
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Everaerts (LEUVEN, Belgium). Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD. 509

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The contribution of Aspergillus fumigatus to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020



Aspergillus fumigatus during stable state and exacerbations of COPD
Source: Eur Respir J 2014; 43: 64-71
Year: 2004




Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients through coughing
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018

Aspergillus fumigatus sensitization in COPD and smokers
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Interleukin-10 genotypes and airways colonization by Aspergillus fumigatus in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005

Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Allergic bronchopulmonary aspergillosis (ABPA) by Aspergillus flavus
Source: Eur Respir J 2001; 18: Suppl. 33, 218s
Year: 2001

Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011


Tracheal oxalosis associated with Aspergillus niger tracheobronchitis
Source: Eur Respir J 2013; 41: 995-997
Year: 2013


Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection>
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
Source: Eur Respir J 2006; 28: 352-357
Year: 2006



IgE sensitization to Aspergillus fumigatus among children in allergological centre of Saratov
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

What is the significance of aspergillus fumigatus in BAL in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011